Abbott Laboratories (ABL.DE) XETRA
Currency In EUR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 217.6B |
| Enterprise Value | 224.14B |
| P/E Ratio | 25.59 |
| PEG Ratio | -0.48 |
| Price/Sales Ratio | 3.55 |
| Price/Book Ratio | 3.09 |
| Enterprise/Revenue | 4.16 |
| Enterprise/EBITDA | 16.74 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.14 |
| Operating Margin | 0.18 |
AD
Management Effectiveness
| Return On Assets | 0.06 |
| Return On Equity | 0.12 |
Income Statement
| Revenue | 44.33B |
| Revenue/Share | 25.84 |
| Gross Profit | 25.01B |
| EBITDA | 12.08B |
| Net Income | 6.52B |
| Diluted EPS | 3.73 |
Balance Sheet
| Total Cash | 7.3B |
| Total Cash/Share | 4.18 |
| Total Debt | 34.05B |
| Total Debt/Equity | 0.65 |
| Current Ratio | 1.39 |
| Book Value Per Share | 30.17 |
Price History
| 52-Week Change | -28.07 |
| 52-Week High | 116.56 |
| 52-Week Low | 70.1 |
| Moving Average 50 Days | 77.18 |
| Moving Average 200 Days | 94.28 |
Statistics
| Average Volume | 1,507 |
| Shares Outstanding | 1.74B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 2.44 |
| Trailing Annual Dividend Yield | 2.65 |
| Payout Ratio | 0.67 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
